Table of Contents User Guide..................................................................... 2 A. Description of the Donation Service Area (DSA) Served by FLUF............ 6 B. US Population Density, Deaths, Death Rates, and Donations.................. 7 C. Organ Utilization............................................................... 11 D. Description of Donors Recovered by FLUF.................................... 16 E. Programs Transplanting Organs Procured by FLUF........................... 17 F. Transplants Facilitated by FLUF................................................ 24 G. Counties Served by FLUF...................................................... 34 under contract with the Health Resources and Services Administration (HRSA). Page: 1
User Guide This report contains a wide range of useful information about the operations and performance of the Organ Procurement Organization (OPO). The report is divided in seven main sections: A. Description of the Donation Service Area (DSA) Served by FLUF B. US Population Density, Deaths, Death Rates, and Donations C. Organ Utilization D. Description of Donors Recovered by FLUF E. Programs Transplanting Organs Procured by FLUF F. Transplants Facilitated by FLUF G. Counties Served by FLUF Some common abbreviations are used throughout the report: Organ Designars: HR: Heart IN: Intestine KI: Kidney LI: Liver LU: Lung PA: Pancreas Other Abbreviations: DSA: Donation Service Area DBD: Donation after Brain Death DCD: Donation after Circulary Death Section A: Description of the Donation Service Area Served by FLUF Section A provides a broad geographic overview of the area of the United States served by the OPO. Figure A1 shows the DSA within the context of the nation with the location of the OPO s headquarters indicated on the map. Figure A2 zooms in on the OPO s DSA and highlights counties served by the OPO. SRTR staff worked with each OPO during 2013 determine the list of counties functionally served by the OPO. This list may not necessarily match the list of official CMS-designated counties for each OPO. For a full description of the counties served, see Section G. Figure A2 also shows the locations of transplant programs within the DSA. All transplant programs within the DSA are identified in Table A1. Note that only programs that performed at least one transplant of the various types from 07/01/2013 06/30/2014 are listed in Table A1. under contract with the Health Resources and Services Administration (HRSA). Page: 2
User Guide Section B: US Population Density, Deaths, Death Rates, and Donations Section B describes the population of the US served by the OPO. Figure B1 provides a map of the population density of the US with the DSA highlighted. Summary statistics are provided for the OPO along with an indication of where the OPO ranks among the 58 OPOs. Figures B2 and B3 are similar, but provide different perspectives, with Figure B2 focusing on deaths per 1000 population and Figure B3 focusing on deaths per 1000 square miles covered by the OPO. Note that each of these maps, population data are derived from the US Census Bureau. For a more detailed description of the counties served by this OPO, see section G. Table B1 provides counts of deaths meeting the eligible death definition (as reported by each donor hospital) along with counts of donors procured by the OPO (tal donors and those meeting the eligible death definition). To contextualize these numbers, minimum, maximum, and average values for all 58 OPOs are provided. The observed donation rate per 100 eligible deaths and the expected donation rate per 100 eligible deaths are provided. The expected donation rate is determined from a statistical model and is described in the OSR Technical Methods document. The standardized donation rate ratio is the observed donation rate divided by the expected donation rate. The P Value indicates if the standardized donation rate ratio is statistically significantly different from 1.0. If the P Value is less than 0.05, we have evidence that the standardized ratio is either higher or lower than expected and that this difference is likely not due chance alone. Additionally, the 95% confidence interval (CI) of the standardized donation rate ratio will not include 1.0 if the P Value is less than 0.05. The standardized donation rate ratio is put in context of all 58 OPOs in Figure B4. Figure B4 is arranged by the number of eligible deaths within each DSA so that you can more easily compare the OPO with OPOs of similar size. Finally, trends in donations per 100 eligible deaths over the five most recent one-year periods are shown in Figure B5. Table B2 provides counts of eligible deaths and actual donors procured from each of the donor hospitals served by the OPO. Additional Donors are those donors that did not meet the eligible death definition. Observed and expected donation rates per 100 eligible death are provided for each donor hospital, but tests of whether each hospitals donation rate is significantly higher or lower than expected are not performed due generally small sample sizes within each donor hospital. Section C: Organ Utilization Section C begins by providing 5-year trends in the numbers of organs transplanted by organ type and donor type (donations after brain death [DBD] and donations after circulary death [DCD]). Figure C1, Figure C2, and Figure C3 present counts of transplants in tal (Figure C1), for DBD donors (Figure C2), and for DCD donors (Figure C3). For the purpose of counting transplants, right and left kidneys are counted separately, as are right and left lungs. The under contract with the Health Resources and Services Administration (HRSA). Page: 3
User Guide Donors count simply counts the donors from whom at least one organ was recovered for the purpose of transplant. Table C1 then provides a full description of the numbers of donors authorized by each organ type along with the ultimate disposition of the organs for the most recent one-year period. In Table C1, kidneys and lungs are counted individually yielding approximately twice the number of organs authorized when compared the other organs. Table C2 presents organ-specific donation rates per 100 eligible deaths. Expected rates are based on a statistical model detailed in the OSR Technical Methods document. If the P Value is less than 0.05, we have evidence that the difference between the observed and expected organ-specific donation rate is not simply due chance. Figure C4 presents the standardized organ-specific donation rate ratios along with their 95% confidence intervals (CI). Figures C5 and C6 present organs recovered per donor and organs transplanted per donor, respectively. Each of these figures presents where the OPO stands relative all 58 OPOs with the OPO s performance indicated by the diamond. The distribution of all 58 OPOs is shown by the bell-shaped curve with the national average of all 58 OPOs indicated by the horizontal line. Trends in organs transplanted per donor over the previous five 1-year periods are shown in Figure C7. Table C3 presents the Observed vs. Expected organ yields for the most recent 2-year period. For a full description of the models used by the SRTR estimate expected organ yields, please visit our website at www.srtr.org. The Observed Expected (O/E) organ-specific ratios are then presented graphically in Figure C8 so that it can be seen where the OPO stands relative the other OPOs. In Figure C8, the x-axis is the number of donors procured by each OPO so that one can compare the OPO with other OPOs that are relatively the same size. Figures C9, C10, and C11 present data specific donors after brain death (DBD) and donors after circulary death (DCD). Figure C9 shows 5-year trends in the number of organs transplanted per donor by DBD and DCD status with comparisons the US as a whole. Figures C10 and C11 present where the OPO stands in relation all 58 OPOs with regards organs transplanted per DBD/DCD donor. Section D: Description of Donors Recovered by FLUF Section D presents tabular descriptions of the donor recovered by the OPO. Data are shown for the most recent two years with comparisons the US as a whole. Breakdowns are provided for race, age, gender, blood type, cause of death, and DCD status. under contract with the Health Resources and Services Administration (HRSA). Page: 4
User Guide Section E: Programs Transplanting Organs Procured by FLUF Section E presents flight maps showing locations of programs that transplanted organs from the OPO. Separate maps are provided for each organ type. Note that all arrows originate from the location of the OPO s headquarters rather than the location of each donor hospital. In addition, many programs within the OPO s DSA will not be visible on the map due scale. Each map is accompanied by a table providing the full detail of each program transplanting organs recovered by the OPO. Geographic indicars are provided based on whether the program is within the same DSA (Local), within the same OPTN region but not the same DSA (Regional), or not within the same DSA or OPTN region (National). Section F: Transplants Facilitated by FLUF Section F provides tabular descriptions of the recipients that received organs that were procured by the OPO, regardless of where the transplant ok place. Separate tables are provided by each organ type along with separate tables for heart-lung recipients and kidney-pancreas recipients. The most recent two years are provided along with data for the US as a whole for the same two periods. Breakdowns are provided by demographic facrs (race, age, and gender) and clinical facrs (blood type, PRA [kidney, pancreas, and kidney-pancreas only], medical urgency status [if applicable], Expanded Criteria Donor status [kidney only], and primary cause of disease). Section G: Counties Served by FLUF Table G1 presents the counties served by the OPO. Counties are ordered alphabetically within state. For the purposes of this report, counties are those actually served by the OPO and do not necessarily reflect CMS assignments. SRTR staff worked closely with the OPOs during 2013 determine the correct county assignments. Please contact the SRTR at srtr@srtr.org if you feel any counties are assigned in error. If more than one OPO serves different donor hospitals within the same county, the county is indicated as a shared county and the OPO sharing the county is indicated by OPO code. For the purpose of calculating population density, land area, and death rates presented in Section B, the one--one CMS county OPO assignment is used. under contract with the Health Resources and Services Administration (HRSA). Page: 5
A. Description of the Donation Service Area (DSA) Served by FLUF Figure A1. Donation service area of FLUF Location of OPO headquarters Figure A2. Counties served by FLUF Table A1. Transplant programs* in FLUF's DSA Hospital Name (Code) HR IN KI LI LU PA Mayo Clinic Florida (FLSL) X X X X X Shands Hospital at The University of Florida (FLUF) X X X X X Locations of transplant programs (See Tables A1 and G1 for more details) *Performed at least one transplant of that type from 07/01/2013 06/30/2014. under contract with the Health Resources and Services Administration (HRSA). Page: 6
LifeQuest Organ Recovery Services B. US Population Density, Deaths, Death Rates, and Donations Figure B1. Population density* Population of FLUF's DSA: 3,869,260. This ranks 34th among the 58 DSAs (1st is the highest). Persons Per Square Mile < 13 Land area of FLUF's DSA: 25,226 square miles. This ranks 37th among the 58 DSAs (1st is the highest). 13-33 33-67 67-187 > 187 *US Census Bureau, 2012 projected population/2010 land area Figure B2. Deaths per 1000 population* Deaths within FLUF's DSA: 35,817. This ranks 32nd among the 58 DSAs (1st is the highest). Deaths Per 1000 Population < 7.63 7.63-9.24 Death rate within FLUF's DSA: 9.26. This ranks 13th among the 58 DSAs (1st is the highest). 9.24-10.61 10.61-12.13 *US Census Bureau, 2012 projected death (includes all deaths, not limited eligible deaths) and population > 12.13 Figure B3. Deaths per 1000 square miles* Deaths per 1000 square miles within FLUF's DSA: 1,420. This ranks 28th among the 58 DSAs (1st is the highest). Deaths Per 1000 Square Miles < 130 130-355 355-669 *US Census Bureau, 2012 projected death (includes all deaths, not limited eligible deaths) and population under contract with the Health Resources and Services Administration (HRSA). 669-1630 > 1630 Page: 7
B. US Population Density, Deaths, Death Rates, and Donations Table B1. Measures of donation rate*, 07/01/2013 06/30/2014 FLUF National Min. Average Max. Eligible Deaths 145 31 158.71 499 Deceased Donors (All) 134 39 145.00 457 Deceased Donors Meeting Eligibility Criteria 103 18 114.59 355 Observed Donation Rate Per 100 Eligible Deaths 71.0 58.1 72.2 90.9 Expected Donation Rate Per 100 Eligible Deaths 72.2 Standardized Donation Rate Ratio (95% CI) 0.98 (0.87,1.08) P Value 0.759 *The donation rate is calculated as the number of deceased donors meeting eligibility criteria per 100 eligible deaths. Figure B4. Standardized donation rate ratios (observed/expected), 07/01/2013 06/30/2014 1.2 Standardized Donation Rate Ratios 1.1 1.0 0.9 0.8 0.7 FLUF Other OPOs 0 200 400 600 Eligible Deaths Figure B5. Donations per 100 eligible deaths, 07/01/2009 06/30/2014 Donations per 100 Eligible Deaths 100 80 60 40 20 0 25.2 26.4 36.4 30.1 31.7 Jul 2009 Jun 2010 Jul 2010 Jun 2011 62.6 63.6 69.1 63.2 63.4 Jul 2011 Jun 2012 64.1 66.7 77.2 64.7 66.2 Heart Kidney Liver Lung Pancreas 18.3 Jul 2012 29.5 27.2 19.9 25.5 Jul 2013 10.7 9.3 13.0 8.1 13.8 under contract with the Health Resources and Services Administration (HRSA). Page: 8
B. US Population Density, Deaths, Death Rates, and Donations Table B2. Measures of donation rates by hospital, 07/01/2013 06/30/2014 Hospital Name City, State Fort Waln Beach Medical Center Fort Waln Beach, FL Malcom Randall Va Medical Center Gainesville, FL Shands At Uf Gainesville, FL Citrus Memorial Health System Inverness, FL Baptist Medical Center - Jacksonville Jacksonville, FL Baptist Medical Center South Jacksonville, FL Mayo Clinic-Jacksonville Jacksonville, FL Memorial Medical Center - Jacksonvil Jacksonville, FL Shands Jacksonville Jacksonville, FL St Vincents Medical Center Riverside Jacksonville, FL Wolfson Childrens Hospital Jacksonville, FL Munroe Regional Medical Center Ocala, FL Ocala Regional Medical Center Ocala, FL West Marion Community Hospital Ocala, FL Orange Park Medical Center Inc Orange Park, FL Bay Medical Center Panama City, FL Gulf Coast Medical Center Panama City, FL Baptist Hospital - Pensacola Pensacola, FL Sacred Heart Health System - Pensacola Pensacola, FL Flagler Hospital Saint Augustine, FL Donors Meeting Eligible Death Eligible Def. Deaths Observed Donation Rate Expected Donation Rate Additional Donors 2 2 100 67.3 1 1 1 100 75.9 0 21 30 70 69.5 5 0 0 -- -- 1 1 3 33.3 60.7 0 0 0 -- -- 1 4 5 80 61.3 6 0 2 0 78.2 0 28 34 82.4 71.3 8 1 1 100 60.2 0 3 7 42.9 70.7 0 1 3 33.3 76.1 0 4 5 80 77.1 2 0 0 -- -- 1 0 1 0 53.7 0 1 4 25 81.5 1 4 5 80 72.1 0 6 8 75 67.5 2 12 15 80 76.9 2 2 3 66.7 77.7 0 under contract with the Health Resources and Services Administration (HRSA). Page: 9
B. US Population Density, Deaths, Death Rates, and Donations Table B2. Measures of donation rates by hospital, 07/01/2013 06/30/2014 (continued) Hospital Name City, State Capital Regional Medical Center Tallahassee, FL Tallahassee Memorial Hospital Tallahassee, FL Donors Meeting Eligible Death Eligible Def. Deaths Observed Donation Rate Expected Donation Rate Additional Donors 1 1 100 54.7 0 11 15 73.3 73.2 1 Total 103 145 31 under contract with the Health Resources and Services Administration (HRSA). Page: 10
C. Organ Utilization Figure C1. Total donors and organs transplanted 250 80 200 150 100 50 Donors KI LI 60 40 20 HR IN LU PA 0 0 Jul-09 Jun-10 Jul-10 Jun-11 Jul-11 Jun-12 Jul-12 Jun-13 Jul-13 Jun-14 Jul-09 Jun-10 Jul-10 Jun-11 Jul-11 Jun-12 Jul-12 Jun-13 Jul-13 Jun-14 Figure C2. DBD donors and organs transplanted 200 80 150 100 50 Donors KI LI 60 40 20 HR IN LU PA 0 0 Jul-09 Jun-10 Jul-10 Jun-11 Jul-11 Jun-12 Jul-12 Jun-13 Jul-13 Jun-14 Jul-09 Jun-10 Jul-10 Jun-11 Jul-11 Jun-12 Jul-12 Jun-13 Jul-13 Jun-14 Figure C3. DCD donors and organs transplanted 40 6 30 20 10 Donors KI LI 4 2 HR IN LU PA 0 0 Jul-09 Jun-10 Jul-10 Jun-11 Jul-11 Jun-12 Jul-12 Jun-13 Jul-13 Jun-14 Jul-09 Jun-10 Jul-10 Jun-11 Jul-11 Jun-12 Jul-12 Jun-13 Jul-13 Jun-14 under contract with the Health Resources and Services Administration (HRSA). Page: 11
C. Organ Utilization Table C1. Organ utilization, 07/01/2013 06/30/2014 Organ Organs Authorized Not Recovered* Recovered Not for Transplant* Recovered for Transplant, Not Transplanted* Recovered for Transplant, Transplanted* Heart 127 79 2 0 46 Intestine 131 124 6 0 1 Kidney 266 42 2 42 180 Liver 134 8 1 10 116 Lung 264 167 26 1 70 Pancreas 131 107 4 2 18 *Each liver or pancreas segment is counted separately. Pancreas islet cells are not included. Table C2. Organ specific donation rates per 100 eligible deaths*, 07/01/2013 06/30/2014 Figure C4. Standardized donation rate ratio, 07/01/2013 06/30/2014 Organ Observed Expected P Value Heart 31.7 26.4 0.083 Kidney 63.4 66.9 0.389 Liver 66.2 65.3 0.821 Lung 25.5 17.6 <0.01 Pancreas 13.8 13.8 0.995 *Organ-specific rates are calculated as the number of deceased donors meeting eligibility criteria donating at least one organ of that type per 100 eligible deaths. Standardized donation rate ratio 1.8 1.6 1.4 1.2 1.0 0.8 0.6 1.45 1.2 1.01 0.95 HR KI LI LU PA 1 Figure C5. Organs recovered per donor, 07/01/2013 06/30/2014 (unadjusted for donor characteristics) 4.0 0.5 0.4 0.06 2.0 1.9 0.9 0.6 0.5 0.25 3.5 3.0 ALL 0.3 0.2 0.1 HR 0.04 0.02 0.00 IN 1.8 1.7 1.6 1.5 KI 0.8 0.7 0.6 LI 0.4 0.3 0.2 0.1 0.0 LU 0.20 0.15 0.10 0.05 PA FLUF OPO Average under contract with the Health Resources and Services Administration (HRSA). Page: 12
C. Organ Utilization Figure C6. Organs transplanted per donor, 07/01/2013 06/30/2014 (unadjusted for donor characteristics) 3.5 3.0 0.5 0.4 0.3 0.2 0.06 0.05 0.04 0.03 0.02 1.8 1.6 1.4 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.25 0.20 0.15 0.10 2.5 ALL 0.1 HR 0.01 0.00 IN 1.2 KI 0.6 LI 0.1 0.0 LU 0.05 PA FLUF OPO Average Figure C7. Trends in organs transplanted per donor 7 1.0 1.0 2.0 6 5 0.8 0.8 1.5 4 3 0.6 0.4 0.6 0.4 1.0 2 1 0 2.84 2.99 3.30 3.13 3.22 ALL 0.2 0.0 0.25 0.25 0.40 0.32 0.34 HR 0.2 0.0 0.03 0.01 0.03 0.01 0.01 IN 0.5 0.0 1.27 1.31 1.37 1.52 1.34 KI 1.0 0.8 0.6 1.0 0.8 0.6 1.0 0.8 0.6 Jul-2009 Jun-2010 Jul-2010 Jun-2011 0.4 0.4 0.4 Jul-2011 Jun-2012 0.2 0.0 0.86 0.80 0.92 0.86 0.87 LI 0.2 0.0 0.30 0.54 0.50 0.35 0.52 LU 0.2 0.0 0.12 0.07 0.09 0.06 0.13 PA Jul-2012 Jun-2013 Jul-2013 Jun-2014 under contract with the Health Resources and Services Administration (HRSA). Page: 13
C. Organ Utilization Table C3. Observed and expected organ yield, 07/01/2012 06/30/2014 Number of Donors: 259 Aggregate Organ Heart Intestine Kidney Liver Lung* Pancreas Observed Number of Transplanted Organs Expected Number of Transplanted Organs Observed Number of Transplanted Organs per 100 Donors Expected Number of Transplanted Organs per 100 Donors 771 86 2 370 223 64 26 745 81 3 374 192 59 36 297.7 33.2 0.8 142.9 86.1 24.7 10 287.6 31.3 1.3 144.3 74.1 22.7 13.9 Observed per 100-10.1 1.9-0.5-1.4 12 2-3.9 Expected per 100 Observed Expected 1.04 1.06 0.6 0.99 1.16 1.09 0.72 (O/E) Ratio P Value 0.056 0.396 0.306 0.754 <0.01 0.276 0.010 *Lung yield is calculated as the number of donors that had at least one lung transplanted. Figure C8. Observed/expected yield by organ, 07/01/2012 06/30/2014 (adjusted) Obs/Exp Ratio 1.4 1.3 1.2 1.1 1 0.9 0.8 0.7 Heart Obs/Exp Ratio 3.2 4 2.4 1.6 0.8 0 Intestine Obs/Exp Ratio 1.2 1.1 1 0.9 Kidney 0 200 600 1000 Number of Donors 0 200 600 1000 Number of Donors 0 200 600 1000 Number of Donors Obs/Exp Ratio 1.2 1.1 1 0.9 0.8 Liver Obs/Exp Ratio 1.3 1 0.7 0.4 0.1 Lung Obs/Exp Ratio 2.2 1.7 1.2 0.7 0.2 Pancreas 0 200 600 1000 Number of Donors 0 200 600 1000 Number of Donors FLUF Other OPOs 0 200 600 1000 Number of Donors under contract with the Health Resources and Services Administration (HRSA). Page: 14
C. Organ Utilization Figure C9. Trends in tal organs transplanted per DBD/DCD donor 4 Jul-2009 Jun-2010 Jul-2010 Jun-2011 Jul-2011 Jun-2012 Jul-2012 Jun-2013 Jul-2013 Jun-2014 3 2 1 0 2.9 3.1 3.5 3.4 3.6 3.2 3.3 3.2 3.2 3.3 2.4 2.4 2.2 2.0 1.7 1.9 1.9 1.9 1.8 DBD(FLUF) DBD(US) DCD(FLUF) DCD(US) 1.9 Figure C10. Total organs transplanted per DBD donor, 07/01/2013 06/30/2014 (unadjusted for donor characteristics) 4.0 3.5 3.0 2.5 ALL 0.6 0.5 0.4 0.3 0.2 0.1 HR 0.08 0.06 0.04 0.02 0.00 IN 1.8 1.6 1.4 1.2 1.0 KI 1.00 0.95 0.90 0.85 0.80 0.75 0.70 LI 0.6 0.4 0.2 0.0 LU 0.30 0.25 0.20 0.15 0.10 0.05 PA FLUF OPO Average Figure C11. Total organs transplanted per DCD donor, 07/01/2013 06/30/2014 (unadjusted for donor characteristics) 3.0 2.0 1.0 0.30 2.5 2.0 1.5 ALL Insufficient Data HR Insufficient Data IN 1.5 1.0 0.5 KI 0.8 0.6 0.4 0.2 0.0 LI 0.25 0.20 0.15 0.10 0.05 0.00 LU 0.15 0.10 0.05 0.00 PA FLUF OPO Average under contract with the Health Resources and Services Administration (HRSA). Page: 15
D. Description of Donors Recovered by FLUF Table D1. Characteristics of all deceased donors recovered, 07/01/2012 06/30/2014 This OPO United States Number of Donors 125 134 8,161 8,410 Race (%) White 69.6 64.2 66.2 66.3 African-American 24.8 29.9 17.3 17.1 Hispanic/Latino 4.8 3.7 13.0 13.1 Asian 0.8 1.5 2.9 2.8 Other 0.0 0.7 0.5 0.7 Age (%) 0-1 Years 2.4 3.0 2.7 2.3 2-11 Years 5.6 3.7 3.2 3.4 12-17 Years 3.2 3.7 4.5 4.3 18-34 Years 32.0 26.1 27.6 28.2 35-49 Years 30.4 26.1 26.2 26.1 50-64 Years 23.2 32.1 28.2 28.0 65+ Years 3.2 5.2 7.5 7.6 Gender (%) Male 52.8 56.0 59.5 59.7 Female 47.2 44.0 40.5 40.3 Blood Type (%) O 43.2 50.7 47.9 47.6 A 38.4 33.6 36.6 37.0 B 16.8 12.7 12.1 12.1 AB 1.6 3.0 3.3 3.2 Cause of Death (%) Anoxia 28.0 26.9 30.4 32.8 Stroke 36.8 32.8 34.8 32.8 CNS Tumor 0.0 0.7 0.4 0.5 Head Trauma 35.2 39.6 32.2 31.4 Other 0.0 0.0 2.2 2.5 Unknown 0.0 0.0 0.0 0.0 Donors After Cardiac Death (%) 18.4 17.9 13.6 15.0 under contract with the Health Resources and Services Administration (HRSA). Page: 16
E. Programs Transplanting Organs Procured by FLUF Figure E1. Programs transplanting hearts procured by FLUF, 07/01/2013 06/30/2014* Location of OPO headquarters * Transplants within the local area of the OPO are not always visible on the map due scale. See Table E1 for full details. Table E1. Programs transplanting hearts procured by FLUF, 07/01/2013 06/30/2014 Hospital Name (Code) Geography* Transplants Mayo Clinic Florida (FLSL) Local 14 Shands Hospital at The University of Florida (FLUF) Local 15 All Children's Hospital (FLAC) Regional 1 Arkansas Children's Hospital (ARCH) Regional 1 Tampa General Hospital (FLTG) Regional 1 University of Alabama Hospital (ALUA) Regional 1 Carolinas Medical Center (NCCM) National 1 Duke University Hospital (NCDU) National 5 Inova Fairfax Hospital (VAFH) National 1 Johns Hopkins Hospital (MDJH) National 1 Nationwide Children's Hospital (OHCH) National 1 Rush University Medical Center (ILPL) National 1 Sentara Norfolk General Hospital (VANG) National 2 University of North Carolina Hospitals (NCMH) National 1 * Local = within same DSA; Regional = within same OPTN region, but not same DSA; National = not within same DSA or OPTN region under contract with the Health Resources and Services Administration (HRSA). Page: 17
E. Programs Transplanting Organs Procured by FLUF Figure E2. Programs transplanting intestines procured by FLUF, 07/01/2013 06/30/2014* Location of OPO headquarters * Transplants within the local area of the OPO are not always visible on the map due scale. See Table E2 for full details. Table E2. Programs transplanting intestines procured by FLUF, 07/01/2013 06/30/2014 Hospital Name (Code) Geography* Transplants Mount Sinai Medical Center (NYMS) National 1 * Local = within same DSA; Regional = within same OPTN region, but not same DSA; National = not within same DSA or OPTN region under contract with the Health Resources and Services Administration (HRSA). Page: 18
E. Programs Transplanting Organs Procured by FLUF Figure E3. Programs transplanting kidneys procured by FLUF, 07/01/2013 06/30/2014* Location of OPO headquarters * Transplants within the local area of the OPO are not always visible on the map due scale. See Table E3 for full details. Table E3. Programs transplanting kidneys procured by FLUF, 07/01/2013 06/30/2014 Hospital Name (Code) Geography* Transplants Mayo Clinic Florida (FLSL) Local 77 Shands Hospital at The University of Florida (FLUF) Local 51 Cleveland Clinic Florida Wesn (FLCC) Regional 4 Emory University Hospital (GAEM) Regional 8 Florida Hospital Medical Center (FLFH) Regional 4 Gulf Coast Medical Center (FLFR) Regional 2 Halifax Medical Center (FLHM) Regional 2 Jackson Memorial Hospital University of Miami School of Medicine (FLJM) Regional 3 Ochsner Foundation Hospital (LAOF) Regional 3 Piedmont Hospital (GAPH) Regional 1 University of Alabama Hospital (ALUA) Regional 1 University of Mississippi Medical Center (MSUM) Regional 1 Albany Medical Center Hospital (NYAM) National 1 Cedars-Sinai Medical Center (CACS) National 2 Duke University Hospital (NCDU) National 1 Froedtert Memorial Lutheran Hospital (WISE) National 1 Hospital of the University of Pennsylvania (PAUP) National 1 Johns Hopkins Hospital (MDJH) National 2 * Local = within same DSA; Regional = within same OPTN region, but not same DSA; National = not within same DSA or OPTN region under contract with the Health Resources and Services Administration (HRSA). Page: 19
E. Programs Transplanting Organs Procured by FLUF Table E3. Programs transplanting kidneys procured by FLUF, 07/01/2013 06/30/2014 (continued) Hospital Name (Code) Geography* Transplants Montefiore Medical Center (NYMA) National 4 Nationwide Children's Hospital (OHCH) National 1 New York-Presbyterian Hospital/ Weill Cornell Medical Center (NYNY) National 1 Ohio State University Medical Center (OHOU) National 1 Rochester Methodist Hospital (Mayo Clinic) (MNMC) National 1 Rush University Medical Center (ILPL) National 1 University of California San Diego Medical Center (CASD) National 1 University of Maryland Medical System (MDUM) National 2 University of Toledo Medical Center (OHCO) National 2 Walter Reed National Military Medical Center at Bethesda (DCWR) National 1 * Local = within same DSA; Regional = within same OPTN region, but not same DSA; National = not within same DSA or OPTN region under contract with the Health Resources and Services Administration (HRSA). Page: 20
E. Programs Transplanting Organs Procured by FLUF Figure E4. Programs transplanting livers procured by FLUF, 07/01/2013 06/30/2014* Location of OPO headquarters * Transplants within the local area of the OPO are not always visible on the map due scale. See Table E4 for full details. Table E4. Programs transplanting livers procured by FLUF, 07/01/2013 06/30/2014 Hospital Name (Code) Geography* Transplants Mayo Clinic Florida (FLSL) Local 65 Shands Hospital at The University of Florida (FLUF) Local 15 Children's of Alabama (ALCH) Regional 2 Emory University Hospital (GAEM) Regional 5 Florida Hospital Medical Center (FLFH) Regional 2 Jackson Memorial Hospital University of Miami School of Medicine (FLJM) Regional 3 Ochsner Foundation Hospital (LAOF) Regional 8 Piedmont Hospital (GAPH) Regional 2 Tampa General Hospital (FLTG) Regional 1 Tulane Medical Center (LATU) Regional 1 University of Alabama Hospital (ALUA) Regional 5 University of Mississippi Medical Center (MSUM) Regional 2 Children's Hospital Medical Center (OHCM) National 1 Children's Hospital of Pittsburgh of UPMC (PACH) National 1 Children's Medical Center of Dallas (TXCM) National 1 Indiana University Health (INIM) National 1 Memorial Hermann Hospital, University of Texas at Housn (TXHH) National 1 * Local = within same DSA; Regional = within same OPTN region, but not same DSA; National = not within same DSA or OPTN region under contract with the Health Resources and Services Administration (HRSA). Page: 21
E. Programs Transplanting Organs Procured by FLUF Figure E5. Programs transplanting lungs procured by FLUF, 07/01/2013 06/30/2014* Location of OPO headquarters * Transplants within the local area of the OPO are not always visible on the map due scale. See Table E5 for full details. Table E5. Programs transplanting lungs procured by FLUF, 07/01/2013 06/30/2014 Hospital Name (Code) Geography* Transplants Mayo Clinic Florida (FLSL) Local 21 Shands Hospital at The University of Florida (FLUF) Local 16 Emory University Hospital (GAEM) Regional 1 Tampa General Hospital (FLTG) Regional 1 University of Alabama Hospital (ALUA) Regional 3 Duke University Hospital (NCDU) National 16 Loyola University Medical Center (ILLU) National 1 Medical University of South Carolina (SCMU) National 2 Temple University Hospital (PATU) National 2 The Methodist Hospital (TXMH) National 2 University of North Carolina Hospitals (NCMH) National 2 University of Texas Medical Branch at Galvesn (TXJS) National 1 University of Virginia Health Sciences Center (VAUV) National 2 * Local = within same DSA; Regional = within same OPTN region, but not same DSA; National = not within same DSA or OPTN region under contract with the Health Resources and Services Administration (HRSA). Page: 22
E. Programs Transplanting Organs Procured by FLUF Figure E6. Programs transplanting pancreata procured by FLUF, 07/01/2013 06/30/2014* Location of OPO headquarters * Transplants within the local area of the OPO are not always visible on the map due scale. See Table E6 for full details. Table E6. Programs transplanting pancreata procured by FLUF, 07/01/2013 06/30/2014 Hospital Name (Code) Geography* Transplants Mayo Clinic Florida (FLSL) Local 11 Shands Hospital at The University of Florida (FLUF) Local 5 Florida Hospital Medical Center (FLFH) Regional 1 Ochsner Foundation Hospital (LAOF) Regional 1 * Local = within same DSA; Regional = within same OPTN region, but not same DSA; National = not within same DSA or OPTN region under contract with the Health Resources and Services Administration (HRSA). Page: 23
F. Transplants Facilitated by FLUF Table F1. Characteristics of deceased donor heart-lung recipients This OPO United States Total Number of Transplants 2 0 24 23 Race (%) White 50.0 -- 62.5 69.6 African-American 0.0 -- 12.5 13.0 Hispanic/Latino 50.0 -- 25.0 8.7 Asian 0.0 -- 0.0 8.7 Other 0.0 -- 0.0 0.0 Age (%) 0-1 Years 50.0 -- 4.2 0.0 2-11 Years 0.0 -- 8.3 8.7 12-17 Years 0.0 -- 12.5 8.7 18-34 Years 50.0 -- 16.7 26.1 35-49 Years 0.0 -- 33.3 26.1 50-64 Years 0.0 -- 20.8 30.4 65+ Years 0.0 -- 4.2 0.0 Gender (%) Male 0.0 -- 58.3 39.1 Female 100.0 -- 41.7 60.9 Blood Type (%) O 100.0 -- 54.2 21.7 A 0.0 -- 20.8 52.2 B 0.0 -- 25.0 21.7 AB 0.0 -- 0.0 4.3 Primary Cause of Disease (%) Congenital Disease 0.0 -- 4.2 13.0 Primary Pulmonary Hypertension 0.0 -- 41.7 39.1 Cystic Fibrosis 0.0 -- 0.0 8.7 Idiopathic Pulmonary Fibrosis 0.0 -- 8.3 26.1 Alpha-1-Antitrypsin Deficiency 0.0 -- 0.0 0.0 Emphysema/COPD 0.0 -- 0.0 4.3 Retransplant/Graft Failure 0.0 -- 0.0 0.0 Other 100.0 -- 45.8 8.7 Missing 0.0 -- 0.0 0.0 under contract with the Health Resources and Services Administration (HRSA). Page: 24
F. Transplants Facilitated by FLUF Table F2. Characteristics of deceased donor heart recipients This OPO United States Total Number of Transplants 38 46 2,388 2,547 Race (%) White 76.3 50.0 63.2 65.9 African-American 13.2 34.8 22.1 20.6 Hispanic/Latino 5.3 8.7 9.0 8.4 Asian 2.6 4.3 4.4 3.9 Other 2.6 2.2 1.3 1.2 Age (%) 0-1 Years 5.3 6.5 5.2 6.4 2-11 Years 7.9 8.7 5.8 4.8 12-17 Years 7.9 6.5 4.7 4.6 18-34 Years 2.6 15.2 9.1 9.3 35-49 Years 13.2 10.9 17.8 16.5 50-64 Years 34.2 34.8 41.5 40.5 65+ Years 28.9 17.4 15.9 17.9 Gender (%) Male 76.3 50.0 69.6 70.4 Female 23.7 50.0 30.4 29.6 Blood Type (%) O 39.5 54.3 39.9 40.7 A 39.5 26.1 39.9 38.3 B 21.1 15.2 14.8 15.1 AB 0.0 4.3 5.4 5.9 Medical Urgency Status (%) 1A 55.3 84.8 66.9 70.2 1B 42.1 13.0 29.6 26.1 2 2.6 2.2 3.4 3.8 Other 0.0 0.0 0.0 0.0 Primary Cause of Disease (%) Cardiomyopathy 44.7 63.0 55.3 56.0 Coronary Artery Disease 39.5 21.7 31.7 31.6 Valvular Heart Disease 0.0 0.0 1.8 1.3 Congenital Heart Disease 15.8 13.0 10.4 10.2 Retransplant/Graft Failure 0.0 0.0 0.0 0.0 Other 0.0 2.2 0.7 0.7 Missing 0.0 0.0 0.0 0.2 under contract with the Health Resources and Services Administration (HRSA). Page: 25
F. Transplants Facilitated by FLUF Table F3. Characteristics of deceased donor intestine recipients This OPO United States Total Number of Transplants 1 1 83 138 Race (%) White 100.0 100.0 65.1 70.3 African-American 0.0 0.0 24.1 12.3 Hispanic/Latino 0.0 0.0 7.2 14.5 Asian 0.0 0.0 2.4 2.9 Other 0.0 0.0 1.2 0.0 Age (%) 0-1 Years 100.0 0.0 16.9 6.5 2-11 Years 0.0 0.0 26.5 23.2 12-17 Years 0.0 0.0 6.0 2.9 18-34 Years 0.0 0.0 14.5 11.6 35-49 Years 0.0 0.0 14.5 28.3 50-64 Years 0.0 100.0 21.7 26.8 65+ Years 0.0 0.0 0.0 0.7 Gender (%) Male 0.0 0.0 56.6 48.6 Female 100.0 100.0 43.4 51.4 Blood Type (%) O 100.0 0.0 54.2 44.2 A 0.0 100.0 36.1 34.1 B 0.0 0.0 8.4 15.9 AB 0.0 0.0 1.2 5.8 Primary Cause of Disease (%) Short Gut Syndrom 100.0 100.0 78.3 73.2 Functional Bowel Problem 0.0 0.0 9.6 8.7 Other 0.0 0.0 12.0 18.1 Missing 0.0 0.0 0.0 0.0 under contract with the Health Resources and Services Administration (HRSA). Page: 26
F. Transplants Facilitated by FLUF Table F4. Characteristics of deceased donor kidney recipients (demographic) This OPO United States Total Number of Transplants 182 160 10,928 11,360 Race (%) White 45.1 49.4 43.4 43.9 African-American 41.8 39.4 31.3 31.0 Hispanic/Latino 7.7 5.6 16.9 16.4 Asian 4.4 5.6 7.2 7.3 Other 1.1 0.0 1.2 1.4 Unknown 0.0 0.0 0.0 0.0 Age (%) 0-1 Years 0.0 0.0 0.1 0.2 2-11 Years 1.6 1.9 1.7 1.5 12-17 Years 1.6 3.1 2.3 2.4 18-34 Years 9.3 10.0 9.5 8.4 35-49 Years 23.1 20.0 24.0 23.1 50-64 Years 42.3 37.5 41.8 42.5 65+ Years 22.0 27.5 20.6 22.0 Gender (%) Male 62.1 57.5 60.6 61.3 Female 37.9 42.5 39.4 38.7 under contract with the Health Resources and Services Administration (HRSA). Page: 27
F. Transplants Facilitated by FLUF Table F5. Characteristics of deceased donor kidney recipients (clinical) This OPO United States Total Number of Transplants 182 160 10,928 11,360 Blood Type (%) O 42.9 44.4 46.2 45.1 A 37.9 31.2 34.9 37.0 B 16.5 16.9 13.3 13.1 AB 2.7 7.5 5.5 4.8 Calculated Panel Reactive Antibody (CPRA%) 0-9 58.8 57.5 52.7 53.7 10-79 15.4 20.0 28.2 27.8 80+ 25.8 22.5 19.1 18.5 Primary Cause of Disease (%) Glomerular Diseases 25.3 28.1 22.3 21.2 Tubular and Interstitial Disease 2.7 2.5 4.6 4.7 Polycystic Kidneys 9.3 7.5 8.3 8.2 Congenital, Familial, Metabolic 3.3 3.8 3.0 3.0 Diabetes 18.1 21.9 26.8 27.3 Renovascular & Vascular Diseases 0.0 0.0 0.1 0.3 Neoplasms 2.2 1.9 0.3 0.4 Hypertensive Nephrosclerosis 29.7 21.2 24.7 24.5 Other Kidney 9.3 13.1 9.5 10.0 Missing 0.0 0.0 0.4 0.3 Kidney from Expanded Criteria Donor (%) Yes 14.8 14.4 14.8 14.5 No 85.2 85.6 85.2 85.5 under contract with the Health Resources and Services Administration (HRSA). Page: 28
F. Transplants Facilitated by FLUF Table F6. Characteristics of deceased kidney-pancreas recipients This OPO United States Total Number of Transplants 7 14 787 728 Race (%) White 71.4 50.0 63.3 61.1 African-American 14.3 35.7 20.6 21.6 Hispanic/Latino 14.3 14.3 11.7 13.5 Asian 0.0 0.0 3.0 3.0 Other 0.0 0.0 1.4 0.8 Age (%) 0-1 Years 0.0 0.0 0.0 0.0 2-11 Years 0.0 0.0 0.0 0.1 12-17 Years 0.0 0.0 0.3 0.0 18-34 Years 28.6 35.7 22.4 23.8 35-49 Years 42.9 50.0 56.0 53.3 50-64 Years 28.6 14.3 21.1 22.7 65+ Years 0.0 0.0 0.3 0.1 Gender (%) Male 85.7 57.1 63.7 61.1 Female 14.3 42.9 36.3 38.9 Blood Type (%) O 57.1 57.1 47.4 48.4 A 42.9 21.4 36.5 34.1 B 0.0 14.3 11.2 12.9 AB 0.0 7.1 5.0 4.7 Calculated Panel Reactive Antibody (CPRA%) 0-9 85.7 64.3 68.4 68.4 10-79 14.3 28.6 25.7 26.1 80+ 0.0 7.1 6.0 5.5 under contract with the Health Resources and Services Administration (HRSA). Page: 29
F. Transplants Facilitated by FLUF Table F7. Characteristics of deceased donor liver recipients (demographic) This OPO United States Total Number of Transplants 109 116 6,032 6,327 Race (%) White 81.7 84.5 69.6 68.3 African-American 3.7 5.2 10.5 10.8 Hispanic/Latino 13.8 9.5 14.3 14.7 Asian 0.9 0.9 4.5 5.1 Other 0.0 0.0 1.1 1.1 Age (%) 0-1 Years 6.4 2.6 3.2 3.2 2-11 Years 2.8 4.3 3.1 2.9 12-17 Years 0.9 0.0 1.5 1.4 18-34 Years 6.4 5.2 4.8 5.0 35-49 Years 5.5 12.1 15.3 14.5 50-64 Years 54.1 53.4 58.3 57.1 65+ Years 23.9 22.4 13.8 15.8 Gender (%) Male 65.1 71.6 65.7 65.2 Female 34.9 28.4 34.3 34.8 under contract with the Health Resources and Services Administration (HRSA). Page: 30
F. Transplants Facilitated by FLUF Table F8. Characteristics of deceased donor liver recipients (clinical) This OPO United States Total Number of Transplants 109 116 6,032 6,327 Blood Type (%) O 38.5 46.6 45.5 44.4 A 40.4 35.3 35.7 36.5 B 15.6 13.8 13.7 14.1 AB 5.5 4.3 5.1 5.0 Medical Urgency Status (%) Status 1A 7.3 3.4 4.7 4.5 Status 1B 3.7 2.6 1.5 1.7 MELD 6-10 13.8 15.5 15.2 14.0 MELD 11-14 13.8 10.3 11.8 11.8 MELD 15-20 19.3 25.0 17.8 16.9 MELD 21-30 30.3 23.3 23.8 21.0 MELD 31-40 8.3 17.2 21.4 26.4 PELD <= 10 0.0 0.9 1.9 1.8 PELD 11-14 0.0 0.9 0.3 0.4 PELD 15-20 1.8 0.0 0.6 0.5 PELD 21-30 0.9 0.0 0.6 0.7 PELD >= 31 0.9 0.9 0.4 0.3 Primary Cause of Disease (%) Acute Hepatic Necrosis 4.6 4.3 4.6 4.7 Non-Cholestatic Cirrhosis 38.5 48.3 58.8 59.2 Cholestatic Liver Disease/Cirrhosis 5.5 6.9 7.6 7.2 Biliary Atresia 5.5 0.9 3.1 2.8 Metabolic Diseases 3.7 4.3 3.3 3.3 Malignant Neoplasms 37.6 29.3 19.1 19.2 Other 4.6 6.0 3.4 3.7 Missing 0.0 0.0 0.1 0.0 under contract with the Health Resources and Services Administration (HRSA). Page: 31
F. Transplants Facilitated by FLUF Table F9. Characteristics of deceased donor lung recipients This OPO United States Total Number of Transplants 27 39 1,847 1,881 Race (%) White 77.8 71.8 83.1 81.6 African-American 18.5 15.4 7.9 8.8 Hispanic/Latino 3.7 10.3 6.8 7.2 Asian 0.0 2.6 1.5 2.0 Other 0.0 0.0 0.7 0.4 Age (%) 0-1 Years 0.0 0.0 0.3 0.4 2-11 Years 0.0 2.6 0.6 0.8 12-17 Years 0.0 0.0 1.7 1.8 18-34 Years 7.4 10.3 10.1 11.0 35-49 Years 22.2 17.9 12.2 11.3 50-64 Years 37.0 46.2 46.6 45.8 65+ Years 33.3 23.1 28.5 29.0 Gender (%) Male 55.6 69.2 60.4 60.2 Female 44.4 30.8 39.6 39.8 Blood Type (%) O 55.6 61.5 48.2 46.4 A 33.3 25.6 37.1 39.1 B 3.7 7.7 10.4 10.7 AB 7.4 5.1 4.2 3.8 Primary Cause of Disease (%) Congenital Disease 0.0 0.0 0.0 0.0 Primary Pulmonary Hypertension 11.1 0.0 5.5 3.8 Cystic Fibrosis 7.4 17.9 14.0 13.5 Idiopathic Pulmonary Fibrosis 44.4 56.4 50.8 53.3 Emphysema/COPD 33.3 15.4 26.9 26.2 Retransplant/Graft Failure 0.0 0.0 0.0 0.0 Other 3.7 10.3 2.9 3.1 Missing 0.0 0.0 0.0 0.1 under contract with the Health Resources and Services Administration (HRSA). Page: 32
F. Transplants Facilitated by FLUF Table F10. Characteristics of deceased donor pancreas recipients This OPO United States Total Number of Transplants 1 4 221 260 Race (%) White 100.0 100.0 77.8 82.7 African-American 0.0 0.0 12.2 8.8 Hispanic/Latino 0.0 0.0 9.5 7.3 Asian 0.0 0.0 0.0 0.4 Other 0.0 0.0 0.5 0.8 Age (%) 0-1 Years 100.0 0.0 5.4 3.1 2-11 Years 0.0 0.0 2.3 8.5 12-17 Years 0.0 0.0 1.4 1.2 18-34 Years 0.0 50.0 16.7 20.8 35-49 Years 0.0 25.0 46.2 36.2 50-64 Years 0.0 25.0 26.7 28.8 65+ Years 0.0 0.0 1.4 1.5 Gender (%) Male 0.0 50.0 48.4 54.2 Female 100.0 50.0 51.6 45.8 Blood Type (%) O 100.0 75.0 42.5 39.2 A 0.0 25.0 42.1 42.7 B 0.0 0.0 10.9 13.1 AB 0.0 0.0 4.5 5.0 Calculated Panel Reactive Antibody (CPRA%) 0-9 100.0 50.0 55.7 54.6 10-79 0.0 50.0 33.9 38.1 80+ 0.0 0.0 10.4 7.3 under contract with the Health Resources and Services Administration (HRSA). Page: 33
G. Counties Served by FLUF Table G1. Counties served by FLUF State Name County Name County FIPS Shared with Florida Alachua County 12001 Florida Baker County 12003 Florida Bay County 12005 Florida Bradford County 12007 Florida Calhoun County 12013 Florida Citrus County 12017 Florida Clay County 12019 Florida Columbia County 12023 Florida Dixie County 12029 Florida Duval County 12031 Florida Escambia County 12033 Florida Franklin County 12037 Florida Gadsden County 12039 Florida Gilchrist County 12041 Florida Gulf County 12045 Florida Hamiln County 12047 Florida Holmes County 12059 Florida Jackson County 12063 Florida Jefferson County 12065 Florida Lafayette County 12067 Florida Leon County 12073 Florida Levy County 12075 Florida Liberty County 12077 Florida Madison County 12079 Florida Marion County 12083 Florida Nassau County 12089 Florida Okaloosa County 12091 Florida Putnam County 12107 Florida Santa Rosa County 12113 Florida St. Johns County 12109 Florida Suwannee County 12121 Florida Taylor County 12123 Florida Union County 12125 Florida Wakulla County 12129 Florida Waln County 12131 Florida Washingn County 12133 under contract with the Health Resources and Services Administration (HRSA). Page: 34